Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

13.23 -0.03 (-0.19%)
Streaming Delayed Price Updated: 3:31 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 686,352
Open 13.29
Bid (Size) 13.23 (300)
Ask (Size) 13.24 (500)
Prev. Close 13.26
Today's Range 13.20 - 13.48
52wk Range 6.685 - 13.37
Shares Outstanding 1,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
1 Small-Cap Stock to Target This Week and 2 That Underwhelm
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory

Performance

YTD
+4.5%
+4.5%
1 Month
+11.5%
+11.5%
3 Month
+26.3%
+26.3%
6 Month
+58.9%
+58.9%
1 Year
+68.2%
+68.2%

More News

Read More
News headline image
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Earnings Scheduled For October 30, 2025 ↗
Via Benzinga
News headline image
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
Topics Stocks
News headline image
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal to Participate in Upcoming Investor Conferences
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares? ↗
Via The Motley Fool
News headline image
Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy
News headline image
Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Russell 2000 Stocks with Warning Signs
Via StockStory
News headline image
Amneal Receives U.S. FDA Approval for Iohexol Injection
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 Stocks Under $50 We Steer Clear Of
Via StockStory
News headline image
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Value Stocks We Find Risky
Via StockStory
News headline image
Why Amneal (AMRX) Stock Is Up Today
Via StockStory
News headline image
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Q3 2025 Earnings: EPS Beats Estimates, Stock Surges on Raised Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Amneal (NASDAQ:AMRX) Beats Q3 Sales Expectations, Stock Soars
Via StockStory
News headline image
Amneal Reports Third Quarter 2025 Financial Results
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Earnings: What To Look For From AMRX
Via StockStory
Topics Artificial Intelligence
News headline image
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
From Amneal Pharmaceuticals LLC
Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 13.23
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 01/08/26 03:31 PM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 13.23K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 13K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.